Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin in Spinal and Bulbar Muscular Atrophy
NCT00851461Phase 4Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Apr 2008
- Primary completion
- Nov 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of goserelin in spinal and bulbar muscular atrophy (SBMA), sponsored by Ramathibodi Hospital. Primary endpoint: Muscle power. Started Apr 2008; status: completed.
02
Drugs
goserelin
03
Conditions
spinal and bulbar muscular atrophy (SBMA)
Beyond the preview
Go deeper on NCT00851461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00851461.